Ingevity Corporation
NGVT
$47.36
$0.731.57%
| Weiss Ratings | NGVT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | NGVT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NGVT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.77 | |||
| Price History | NGVT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.57% | |||
| 30-Day Total Return | 0.96% | |||
| 60-Day Total Return | 1.59% | |||
| 90-Day Total Return | 40.74% | |||
| Year to Date Total Return | 19.78% | |||
| 1-Year Total Return | 2.96% | |||
| 2-Year Total Return | -39.08% | |||
| 3-Year Total Return | -19.15% | |||
| 5-Year Total Return | 25.66% | |||
| 52-Week High % Change | -15.87% | |||
| 52-Week Low % Change | 53.27% | |||
| Price | NGVT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $56.30 | |||
| 52-Week Low Price | $30.90 | |||
| 52-Week Low Price (Date) | Oct 03, 2024 | |||
| 52-Week High Price (Date) | May 03, 2024 | |||
| Valuation | NGVT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.72B | |||
| Enterprise Value | 3.11B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -11.85 | |||
| Earnings Per Share Growth | 5,228.42% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.23 | |||
| Price/Book (Q) | 8.82 | |||
| Enterprise Value/Revenue (TTM) | 2.21 | |||
| Price | $47.36 | |||
| Enterprise Value/EBITDA (TTM) | 8.30 | |||
| Enterprise Value/EBIT | 11.67 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | NGVT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 36.60M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NGVT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 843 740 2300 | |||
| Address | 4920 O'Hear Avenue North Charleston, SC 29405 | |||
| Website | www.ingevity.com | |||
| Country | United States | |||
| Year Founded | 1964 | |||
| Profitability | NGVT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 18.93% | |||
| Profit Margin | -30.59% | |||
| Management Effectiveness | NGVT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 7.16% | |||
| Return on Equity | -- | |||
| Income Statement | NGVT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.41B | |||
| Total Revenue (TTM) | 1.41B | |||
| Revenue Per Share | $38.43 | |||
| Gross Profit (TTM) | 461.00M | |||
| EBITDA (TTM) | 374.60M | |||
| EBIT (TTM) | 266.30M | |||
| Net Income (TTM) | -430.30M | |||
| Net Income Avl. to Common (TTM) | -430.30M | |||
| Total Revenue Growth (Q YOY) | -19.61% | |||
| Earnings Growth (Q YOY) | 114.21% | |||
| EPS Diluted (TTM) | -11.85 | |||
| EPS Diluted Growth (Q YOY) | 114.04% | |||
| Balance Sheet | NGVT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 68.00M | |||
| Cash Per Share (Q) | $1.86 | |||
| Total Current Assets (Q) | 493.20M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 195.20M | |||
| Current Ratio (Q) | 1.867 | |||
| Book Value Per Share (Q) | $5.37 | |||
| Total Assets (Q) | 2.02B | |||
| Total Current Liabilities (Q) | 264.10M | |||
| Total Debt (Q) | 1.45B | |||
| Total Liabilities (Q) | 1.83B | |||
| Total Common Equity (Q) | 195.20M | |||
| Cash Flow | NGVT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -79.50M | |||
| Cash from Financing (TTM) | -70.20M | |||
| Net Change in Cash (TTM) | -25.30M | |||
| Levered Free Cash Flow (TTM) | 206.01M | |||
| Cash from Operations (TTM) | 128.60M | |||
